Micafungin may be safely administered as outpatient parenteral antimicrobial therapy for chronic pulmonary aspergillosis-Reference-Cited by-同舟云学术

Micafungin may be safely administered as outpatient parenteral antimicrobial therapy for chronic pulmonary aspergillosis

Published:2018-10-19 Issue:2 Volume:62 Page:152-156
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Otu Akaninyene A.¹²^ORCID,Bongomin Felix²^ORCID,Bazaz Rohit²,Harris Chris²,Denning David W.²³⁴,Kosmidis Chris²³⁴

Affiliation:

1. Department of Internal Medicine; University of Calabar; Calabar Cross River State Nigeria

2. ECMM Centre of Excellence in Clinical and Laboratory Mycology and Clinical Studies; The National Aspergillosis Centre; Wythenshawe Hospital; Manchester University NHS Foundation Trust; Manchester UK

3. Faculty of Biology, Medicine and Health; The University of Manchester; Manchester UK

4. Manchester Academic Health Science Centre; Education and Research Centre; Wythenshawe Hospital; Manchester University NHS Foundation Trust; Manchester UK

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/myc.12857/fullpdf

Reference14 articles.

1. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review;Denning;Clin Infect Dis,2003

2. Histological study of chronic pulmonary aspergillosis;Tochigi;Diagn Pathol,2015

3. The management of chronic pulmonary aspergillosis: the UK National Aspergillosis Centre approach;Maghrabi;Curr Fungal Infect Rep,2017

4. Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study;Kohno;Med Mycol,2011

5. The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma;Fujita;J Infect Chemother,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review;Journal of Antimicrobial Chemotherapy;2024-06-06

2. Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges;Therapeutic Advances in Infectious Disease;2024-01

3. Chronic Pulmonary Aspergillosis: Clinical Presentation and Management;Seminars in Respiratory and Critical Care Medicine;2023-12-28

4. Successful Integration of Clinical Pharmacists in an OPAT Program: A Real-Life Multidisciplinary Circuit;Antibiotics;2022-08-19

5. Antifungal use via outpatient parenteral antimicrobial therapy;Mycoses;2022-08-16